SkylineDx’s Merlin CP-GEP Test Proven Accurate for SLNB Selection
July 8, 2025
SkylineDx announced that an independent meta-analysis has confirmed the performance of its Merlin CP-GEP assay in correctly stratifying melanoma patients for sentinel lymph node biopsy